
Jean-Claude Labrune, Chairman & CEO, Cegedim Group

Harvey Bale, Jr., MD, former Director-General, IFPMA

Robert Seidman, Former Chief Pharmacy Officer, Wellpoint

Jane Henney, MD, Former FDA Commissioner

P. Roy Vagelos, MD, Chairman Emeritus, Merck

Francis Collins, MD, PhD, Director, National Institutes of Health

Napoleone Ferrara, MD, PhD, Research Fellow, Genentech

Martin Wygod, Chairman, WebMD

Sidney Wolfe, MD, Director, Public Citizen's Health Research Group

Peter Piot, MD, Director, London School of Hygiene and Tropical Medicine

Fernand Sauer, First Director General, European Medicines Agency

Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.

Increasing intergration with the world economy and accession to the Europen Union have been key pillars in talking the growth potential of Romania's pharmaceutical market to greater heights.

Carlos Morel, MD, Director for Technical Development in Health, Oswaldo Cruz Foundation

Three Decades of Politics and Pop Culture ... on Drugs


Richard Barker, former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.

PricewaterhouseCooper's "Global Construction 2020" report predictions

Despite the gloom, most forecasts show the US will stay atop the industry in profits for at least the next generation of products.

Carrying the Weight of the Future

Social media now gives companies a plethora of creative ways to digitally spread recent company news and keep customers informed

HTAs are gridlocked by diverse national requirements, a lack of alignment on processes, and even on the value of their outcomes.

Please fill in all required fields for a chance to win a Kindle and to download special advertising information for the Pharmaceutical Executive 30th Anniversary issue.

Pedal to the Mettle

More bad ideas on how to manage the healthcare burden are circulating beyond the stakeholders that initiated them

Pharma Faceoff is a video program bringing together key opinion leaders from across the healthcare and pharmaceutical industry to debate the key issues of the day

PE 30 Promo

